SEARCH

SEARCH BY CITATION

References

  • 1
    Dambach DM, Smith CA, Lewis RM, Van Winkle TJ. Morphologic, immunohistochemical, and ultrastructural characterization of a distinctive renal lesion in dogs putatively associated with Borrelia burgdorferi infection: 49 cases (1987–1992). Vet Pathol 1997;34:8596.
  • 2
    Goldstein RE, Cordner AP, Sandler JL, et al. Microalbuminuria andcomparison of serologic testing for exposure to Borrelia burgdorferi in nonclinical Labrador and Golden Retrievers. J Vet Diagn Invest 2007;19:294297.
  • 3
    Littman MP. State-of-the-art-review: Lyme nephritis. J Vet Emerg Crit Care 2013a;23:163173.
  • 4
    Yu LP, Smith GN, Brandt KD, et al. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992;35:11501159.
  • 5
    Yu LP, Burr DB, Brandt KD, et al. Effects of oraldoxycycline administration on histomorphometry and dynamics of subchondral bone in a canine model of osteoarthritis. J Rheum 1996;23:137142.
  • 6
    Chou J, Wunschmann A, Hodzic E, et al. Detection of Borrelia burgdorferi DNA in tissues from dogs with presumptive Lyme borreliosis. J Am Vet Med Assoc 2006;229:12601269.
  • 7
    Littman MP, Goldstein RE, Labato MA, et al. ACVIM Small Animal Consensus Statement on Lyme Disease in Dogs: Diagnosis, Treatment, and Prevention. J Vet Intern Med 2006;20:422434.
  • 8
    Littman MP. Diagnosis of infectious diseases of the urinary tract. In: Bartges J, Polzin DJ, eds. Nephrology and Urology of Small Animals. Ames, IA: Blackwell Publishing Ltd; 2011a:241252.
  • 9
    Camacho AT, Guitian FJ, Pallas E, et al. Azotemia and mortality among Babesia microti-like infected dogs. J Vet Intern Med 2004;18:1416.
  • 10
    Littman MP, Wiley CA, Raducha MG, Henthorn PS. Glomerulopathy and mutations in NPHS1 and KIRREL2 in Soft Coated Wheaten Terrier Dogs. Mamm Genome 2013b;24:119126.
  • 11
    Straubinger RK, Summers BA, Chang YF, Appel MJG. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 1997;35:111116.
  • 12
    Straubinger RK, Straubinger AF, Summers BA, et al. Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs. Wien Klin Wochenschr 1998;110:874881.
  • 13
    Straubinger RK, Straubinger AF, Summers BA, Jacobson RH. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study. J Infect Dis 2000;181:10691081.
  • 14
    Straubinger RK. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. J Clin Microbiol 2000a;38:21912199.
  • 15
    Levy SA, O'Connor TP, Hanscom JL, et al. Quantitative measurement of C6 antibody following antibiotic treatment of Bb antibody-positive nonclinical dogs. Clin Vaccine Immunol 2008;15:115119.
  • 16
    Paltrinieri S, Solana-Gallego L, Findatti A, et al. Guidelines for diagnosis and clinical classification of leishmaniasis in dogs. J Am Vet Med Assoc 2010;236:11841191.
  • 17
    Oliva G, Roura X, Crotti A, et al. Guidelines for treatment of leishmaniasis in dogs. J Am Vet Med Assoc 2010;236:11921198.
  • 18
    Plevraki K, Koutinas AF, Kaldrymidou H, et al. Effects of allopurinol treatment on the progression of 538 chronic nephritis in canine leishmaniosis (Leishmania infantum). J Vet Int Med 2006;20:228233.
  • 19
    Pierantozzi M, Roura X, Paltrinieri S, et al. Variation of proteinuria in dogs with leishmaniasis treated with meglumine antimoniate and allopurinol: retrospective study. J Am Anim Hosp Assoc 2013;49(4):231236.
  • 20
    Miró G, Oliva G, Cruz I, et al. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Vet Dermatol 2009;20:397404.